ロード中...
Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma
Tumor-associated myeloid cells (TAMCs) are key drivers of immunosuppression in the tumor microenvironment, which profoundly impedes the clinical response to immune-dependent and conventional therapeutic modalities. As a hallmark of glioblastoma (GBM), TAMCs are massively recruited to reach up to 50%...
保存先:
| 出版年: | Proc Natl Acad Sci U S A |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
National Academy of Sciences
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6876152/ https://ncbi.nlm.nih.gov/pubmed/31712430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1906346116 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|